Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Virology|February 13, 2023
Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 miceChristopher J Peterson, Brett L Hurst, W Joseph Evans, et al.Viruses|October 26, 2024
Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder LinesScott A Gibson, Yanan Liu, Rong Li, et al.Nature Medicine|August 18, 2022
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2Rachel J Hagey, Menashe Elazar, Edward A Pham, et al.Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.Journal of Medicinal Chemistry|April 30, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19Charlotte M N Allerton, Joel T Arcari, Lisa M Aschenbrenner, et al.Journal of Medicinal Chemistry|February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main ProteaseJamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.Pageof 1